Evidence of late-onset infantile spasms

Epilepsia. 1998 Jan;39(1):55-60. doi: 10.1111/j.1528-1157.1998.tb01274.x.

Abstract

Purpose: To underline the unusual but possible occurrence of epileptic spasms (ES) in children >1 year of age.

Methods: Cases in whom onset of spasms occurred after 1 year of age were identified through a retrospective review of the records of all patients referred for ES to the Saint-Vincent de Paul Hôpital (Paris) and American Memorial Hospital (Reims) between 1974 and 1994.

Results: Eighteen cases were identified among the 734 children referred for ES, 18 cases were identified where spasm onset time ranged from 12 to 38 months of age. In 1/3 of the cases, the diagnosis was suspected from the onset of clinical manifestations; in the remaining 2/3, diagnosis was delayed by a mean 6 months (range, 2-25 months). Neurobehavioral regression affected two-thirds of the patients. Modified hypsarrhythmia was present in 11 patients; all but one exhibited major and diffuse spike- and slow-wave activity. EEG abnormalities were detected in the frontal areas in 11 patients. Spasms were cryptogenic in 9 patients. Steroids were administered to 13 patients; these controlled the spasms in 6 patients. Outcome was favorable for both seizures; cognition favorable in only 2 of the 18 patients.

Conclusions: Beginning after the first year of life, ES, or late-onset infantile spasms, are distinct from early Lennox-Gastaut syndrome, although etiology, prognosis and treatment are similar to that for the classical infantile spasms.

MeSH terms

  • Age of Onset
  • Anticonvulsants / therapeutic use
  • Brain / physiopathology
  • Child Behavior Disorders / epidemiology
  • Child, Preschool
  • Comorbidity
  • Diagnosis, Differential
  • Electroencephalography
  • Epilepsy / epidemiology
  • Female
  • Humans
  • Infant
  • Male
  • Prognosis
  • Spasms, Infantile / diagnosis*
  • Spasms, Infantile / epidemiology
  • Spasms, Infantile / physiopathology
  • Syndrome
  • Terminology as Topic
  • Treatment Outcome

Substances

  • Anticonvulsants